RecruitingNot ApplicableNCT05379738

Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological Malignancy

APALLO : Post Allogeneic Stem Cell Transplantation Adapted Physical Activity for Patient With Hematological Malignancies


Sponsor

Centre Hospitalier Universitaire de Nice

Enrollment

75 participants

Start Date

Jun 10, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

It is a study about adaptated physical activity for patients receiving a stem cell transplantation. They will benefit of 6 adaptated individuals lessons at home between 1 month and 3 months after stem cell transplantation. The study's goal is to observe if adaptated activity has an positive impact on weight loss and on life quality.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Patient aged 18 or more
  • Patient with social security
  • Patient who accept the study and sign the consent form
  • Patient programmed for an allogenic stem cell transplantation
  • Patients with a guardianship
  • Patients with a significant additional physic or mental disease

Exclusion Criteria4

  • Patients who did not receive an allogeniac stem cell transplantation
  • Patients still hospitalized between day 30 and day 100 after stem cell transplantation
  • Patients who finally refuses the study
  • Patients who develop a physical or mental incapacity to practice physical activity

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHER6 sessions of adapted physical activity after stem cell transplant

physical assessement before and after stem cell transplant: * weight loss * brachial muscle circumference * grip strength evaluation * short physical battery test psychometric assessment before and after stem cell transplant: * quality of life questionary * physical activities questionary


Locations(1)

CHU NICE, hopital ARCHET 1, hématologie

Nice, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05379738


Related Trials